Clinical Trial Update: THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS) [Phase 3]

View source ↗

Summary

Phase 3 trial update for thrombolysis with alteplase at 0.6 mg/kg in wake-up/unclear-onset stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Stroke | Phase 3 | Status: UNKNOWN